Literature DB >> 22132882

Immunology in the Clinic Review Series; focus on host responses: invariant natural killer T cell activation following transplantation.

J-P Jukes1, N D Jones.   

Abstract

Invariant natural killer T (iNKT) cells have been shown to play a key role in the regulation of immunity in health and disease. However, iNKT cell responses have also been found to influence both rejection and the induction of tolerance following transplantation of allogeneic cells or organs. Although a number of mechanisms have been identified that lead to iNKT cell activation, how iNKT cells are activated following transplantation remains unknown. This review will attempt to identify potential mechanisms of iNKT cell activation in the context of transplantation by applying knowledge garnered from other disease situations. Furthermore, we put forward a novel mechanism of iNKT cell activation which we believe may be the dominant mechanism responsible for iNKT activation in this setting, i.e. bystander activation by interleukin-2 secreted by recently activated conventional T cells.
© 2011 The Authors. Clinical and Experimental Immunology © 2011 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22132882      PMCID: PMC3248084          DOI: 10.1111/j.1365-2249.2011.04500.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  76 in total

1.  NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma.

Authors:  M J Smyth; N Y Crowe; D I Godfrey
Journal:  Int Immunol       Date:  2001-04       Impact factor: 4.823

2.  Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-/- mice.

Authors:  S Maier; C Tertilt; N Chambron; K Gerauer; N Hüser; C D Heidecke; K Pfeffer
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

3.  Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice.

Authors:  L D Poulton; M J Smyth; C G Hawke; P Silveira; D Shepherd; O V Naidenko; D I Godfrey; A G Baxter
Journal:  Int Immunol       Date:  2001-07       Impact factor: 4.823

4.  Decoding the patterns of self and nonself by the innate immune system.

Authors:  Ruslan Medzhitov; Charles A Janeway
Journal:  Science       Date:  2002-04-12       Impact factor: 47.728

5.  Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells.

Authors:  Koh-Hei Sonoda; Masaru Taniguchi; Joan Stein-Streilein
Journal:  J Immunol       Date:  2002-02-15       Impact factor: 5.422

6.  CD1-dependent dendritic cell instruction.

Authors:  Michael S Vincent; David S Leslie; Jenny E Gumperz; Xiaowei Xiong; Ethan P Grant; Michael B Brenner
Journal:  Nat Immunol       Date:  2002-11-04       Impact factor: 25.606

Review 7.  Innate immune responses support adaptive immunity: NKT cells induce B cell activation.

Authors:  Grazia Galli; Sandra Nuti; Simona Tavarini; Luisa Galli-Stampino; Claudia De Lalla; Giulia Casorati; Paolo Dellabona; Sergio Abrignani
Journal:  Vaccine       Date:  2003-06-01       Impact factor: 3.641

8.  Preserved IFN-alpha production of circulating Valpha24 NKT cells in primary lung cancer patients.

Authors:  Shinichiro Motohashi; Seiichiro Kobayashi; Toshihiro Ito; Kumiko K Magara; Osamu Mikuni; Noriaki Kamada; Toshihiko Iizasa; Toshinori Nakayama; Takehiko Fujisawa; Masaru Taniguchi
Journal:  Int J Cancer       Date:  2002-11-10       Impact factor: 7.396

9.  Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4.

Authors:  Christian Termeer; Frauke Benedix; Jonathon Sleeman; Christina Fieber; Ursula Voith; Thomas Ahrens; Kensuke Miyake; Marina Freudenberg; Christopher Galanos; Jan Christoph Simon
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

10.  A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas.

Authors:  Nadine Y Crowe; Mark J Smyth; Dale I Godfrey
Journal:  J Exp Med       Date:  2002-07-01       Impact factor: 14.307

View more
  3 in total

1.  Broadening the translational immunology landscape.

Authors:  M Peakman
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

2.  OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantation.

Authors:  Udo Holtick; Jens-Markus Chemnitz; Alexander Shimabukuro-Vornhagen; Sebastian Theurich; Geothy Chakupurakal; Anke Krause; Anne Fiedler; Leo Luznik; Martin Hellmich; Dominik Wolf; Michael Hallek; Michael von Bergwelt-Baildon; Christof Scheid
Journal:  Eur J Haematol       Date:  2015-03-16       Impact factor: 2.997

3.  Non-glycosidic compounds can stimulate both human and mouse iNKT cells.

Authors:  John-Paul Jukes; Uzi Gileadi; Hemza Ghadbane; Ting-Fong Yu; Dawn Shepherd; Liam R Cox; Gurdyal S Besra; Vincenzo Cerundolo
Journal:  Eur J Immunol       Date:  2016-03-01       Impact factor: 5.532

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.